Notable improvements in physical function, as assessed by the SF-36 score (+ 12.0 vs
Unveiling the prebiotic potential of polyphenols in gut health and metabolism
Nearly 30% of users quit within the first month and over 70% discontinued within two years
Across randomised and prospective studies, the overall pattern suggests that GLP-1RA treatment reduces craving and the desire to consume energy-dense foods in at least a proportion of participants, alongside reductions in overall appetite and energy intake (17, 81)
If a patient stops the medication, diabetes will relapse (if it was controlled, not cured) and weight will likely be regained, as evidenced by trials where cessation led to weight regain trends
Ive focused here on the variants specifically related to blood glucose regulation